“Prediabetes doesn’t matter unless it turns into diabetes.”
Strong confidence because prediabetes identifies increased risk of future diabetes, and randomized evidence shows that intensive lifestyle change and metformin can delay or prevent progression in high-risk adults. Current ADA guidance recommends at least yearly monitoring and structured prevention for appropriate patients.
Prediabetes matters because it signals a higher chance of developing diabetes and often travels with cardiovascular risk factors. Acting during this stage can substantially delay or prevent diabetes for many people.
Prediabetes is a risk category, not a guarantee that diabetes will occur. A1C, fasting glucose and glucose-tolerance testing identify overlapping but different groups. Risk and the best response depend on the result, trend, weight, age, pregnancy history, medicines and other conditions.
Safety note: A1C can be misleading with anemia, altered red-cell turnover, some hemoglobin variants, kidney disease and pregnancy. Do not start medication or extreme dieting from one result without confirming the diagnosis and clinical context.
Talk to a healthcare professional if: Review the result and trend with a clinician, especially if values are rising or you have prior gestational diabetes, overweight or obesity, a strong family history, cardiovascular disease or medicines that raise glucose. Ask whether another glucose test is needed.
Prediabetes is an early risk signal and a useful window for prevention. It deserves follow-up without treating progression as inevitable.
Confirm the result, review your trend and risk factors, and choose a sustainable prevention plan. Structured programs target regular activity, food quality and, when appropriate, modest weight loss; some high-risk people may also benefit from metformin.